Stocks and Investing
Stocks and Investing
Thu, May 23, 2024
[ Thu, May 23rd 2024
] - WOPRAI
[ Thu, May 23rd 2024
] - WOPRAI
[ Thu, May 23rd 2024
] - WOPRAI
[ Thu, May 23rd 2024
] - WOPRAI
[ Thu, May 23rd 2024
] - WOPRAI
[ Thu, May 23rd 2024
] - WOPRAI
[ Thu, May 23rd 2024
] - WOPRAI
[ Thu, May 23rd 2024
] - WOPRAI
[ Thu, May 23rd 2024
] - WOPRAI
[ Thu, May 23rd 2024
] - WOPRAI
[ Thu, May 23rd 2024
] - WOPRAI
[ Thu, May 23rd 2024
] - WOPRAI
[ Thu, May 23rd 2024
] - WOPRAI
[ Thu, May 23rd 2024
] - WOPRAI
[ Thu, May 23rd 2024
] - WOPRAI
[ Thu, May 23rd 2024
] - WOPRAI
[ Thu, May 23rd 2024
] - WOPRAI
[ Thu, May 23rd 2024
] - WOPRAI
[ Thu, May 23rd 2024
] - WOPRAI
[ Thu, May 23rd 2024
] - WOPRAI
[ Thu, May 23rd 2024
] - WOPRAI
[ Thu, May 23rd 2024
] - WOPRAI
[ Thu, May 23rd 2024
] - WOPRAI
[ Thu, May 23rd 2024
] - WOPRAI
[ Thu, May 23rd 2024
] - WOPRAI
[ Thu, May 23rd 2024
] - WOPRAI
[ Thu, May 23rd 2024
] - WOPRAI
[ Thu, May 23rd 2024
] - WOPRAI
Hartaj Singh Maintained (VIRX) at Buy with Decreased Target to $11 on, May 23rd, 2024
Hartaj Singh of Oppenheimer, Maintained "Viracta Therapeutics, Inc." (VIRX) at Buy with Decreased Target from $13 to $11 on, May 23rd, 2024.
Hartaj has made no other calls on VIRX in the last 4 months.
There is 1 other peer that has a rating on VIRX. Out of the 1 peers that are also analyzing VIRX, 0 agree with Hartaj's Rating of Hold.
This is the rating of the analyst that currently disagrees with Hartaj
- Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $4 on, Tuesday, April 16th, 2024
Contributing Sources